Hernán Patricio Garcia Mejía

Dr. Hernán Patricio Garcia Mejía

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
ANAndre Moreira Nicolau
Andre Moreira Nicolau
PSPedro Guimarães Silva
Pedro Guimarães Silva
HMHernán Patricio Garcia Mejía
Hernán Patricio Garcia Mejía
JGJuan F. Granada
Juan F. Granada
GKGrzegorz L. Kaluza
Grzegorz L. Kaluza
PMPEDRO H. C. MELO
PEDRO H. C. MELO
Coronary microvascular obstruction and dysfunction (CMVO) frequently arise following primary percutaneous coronary intervention (PCI), particularly in individuals with myocardial infarction. Despite the restoration of epicardial blood flow, microvascular perfusion might still be compromised, resulting in negative clinical outcomes. CMVO is a complex condition resulting from a combination of ischemia, distal thrombotic embolization, reperfusion injury, and individual susceptibilities such as inflammation and endothelial dysfunction. The pathophysiological features of this condition include microvascular spasm, endothelial swelling, capillary plugging by leukocytes and platelets, and oxidative stress. Traditional angiographic assessments, such as Thrombolysis in Myocardial Infarction (TIMI) flow grade and myocardial blush grade, have limited sensitivity. Cardiac magnetic resonance imaging (CMR) stands as the gold standard for identifying CMVO, while the index of microvascular resistance (IMR) is a promising invasive option. Treatment approaches involve powerful antiplatelet drugs, anticoagulants, and supersaturated oxygen, yet no treatment has been definitively shown to reverse established CMVO. CMVO remains a significant therapeutic challenge in coronary artery disease management. Enhancing the comprehension of its core mechanisms is vital for the development of more effective and personalized treatment strategies.

1 March 2025 in Arquivos Brasileiros de Cardiologia
Verified
Journal Article
Open access
PDF file
HMHernán Patricio Garcia Mejía
Hernán Patricio Garcia Mejía
MNMatheus Carvalho Alves Nogueira
Matheus Carvalho Alves Nogueira
BMBruno Mahler Mioto
Bruno Mahler Mioto
NPNilson Tavares Poppi
Nilson Tavares Poppi
LCLUIZ Antonio Machado Cesar
LUIZ Antonio Machado Cesar
LDLuís Roberto Palma Dallan
Luís Roberto Palma Dallan
Introdução As fístulas coronárias (FCs), são definidas como uma conexão anômala direta entre uma ou mais artérias coronárias com um grande vaso ou câmara cardíaca. A maior parte das FCs drenam em um sistema de menor pressão, como ventrículo direito (VD) 40%, átrio direito (AD) 26%, artéria pulmonar (AP) 17%, seio coronário 7% e vena cava 1%. A apresentação clínica dependerá da localização e volume do shunt gerado pela fístula. Aproximadamente 50% dos casos são assintomáticos e, quando presentes, podem [...] Introdução As fístulas coronárias (FCs), são definidas como uma conexão anômala direta entre uma ou mais artérias coronárias com um grande vaso ou câmara cardíaca. A maior parte das FCs drenam em um sistema de menor pressão, como ventrículo direito (VD) 40%, átrio direito (AD) 26%, artéria pulmonar (AP) 17%, seio coronário 7% e vena cava 1%. A apresentação clínica dependerá da localização e volume do shunt gerado pela fístula. Aproximadamente 50% dos casos são assintomáticos e, quando presentes, podem

7 October 2026 in JACC: Case Reports
Verified
Journal Article
Open access
HMHernán Patricio Garcia Mejía
Hernán Patricio Garcia Mejía
MGMarco Antonio Smiderle Gelain
Marco Antonio Smiderle Gelain
PJPedro Sérgio Soares Jallad
Pedro Sérgio Soares Jallad
ANAndre Moreira Nicolau
Andre Moreira Nicolau
INIsabella Diniz Novaes
Isabella Diniz Novaes
FBFabio S. de Brito
Fabio S. de Brito

1 January 2026 in Arquivos Brasileiros de Cardiologia
Verified
Journal Article
Open access
HMHernán Patricio Garcia Mejía
Hernán Patricio Garcia Mejía
HMHeleuterio da Conceição Nicolau Madogolele
Heleuterio da Conceição Nicolau Madogolele
MBManuela Cristina Ribeiro Dias Barroso
Manuela Cristina Ribeiro Dias Barroso
MNMatheus Carvalho Alves Nogueira
Matheus Carvalho Alves Nogueira
KMKevin Rafael de Paula Morales
Kevin Rafael de Paula Morales
FFFábio Fernandes
Fábio Fernandes

23 October 2025 in International Journal of Cardiovascular Sciences
Verified
Journal Article
Closed access
CRCristhian Espinoza Romero
Cristhian Espinoza Romero
HMHernán Patricio Garcia Mejía
Hernán Patricio Garcia Mejía
FFFábio Fernandes
Fábio Fernandes
Acute heart failure (AHF) remains a leading cause of hospitalization and cardiovascular mortality worldwide, with an even greater burden in low- and middle-income countries. In Brazil, in-hospital mortality for AHF is approximately 12%, compared to 4% reported in high-income countries., In this context, the prospective study by Ferigato et al., conducted at a public hospital in São Paulo, assessed the prognostic value of C-reactive protein (CRP) in patients with AHF. This investigation is particularly relevant given the structural limitations of

31 October 2026 in JACC: Case Reports
Verified
Journal Article
Open access
EPEstêvão Magalhães Pardi
Estêvão Magalhães Pardi
AFAntônio Fernando Diniz Freire
Antônio Fernando Diniz Freire
HMHernán Patricio Garcia Mejía
Hernán Patricio Garcia Mejía
PBPedro H.F. de Brito
Pedro H.F. de Brito
FBFabio Sandoli de Brito
Fabio Sandoli de Brito
AAAlexandre Abizaid
Alexandre Abizaid